<Table 2>
 <caption text="

         Vaccination with helminth extracellular vesicles (EVs).
        
">
 </caption>
 <row row="0">
  <cell col="0" row="0" text="
           Species
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="0" text="
           Vaccination method used
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="0" text="
           Results
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="0" text="
           Antibodies
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="4" row="0" text="
           Reference
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="1">
  <cell col="0" row="1" text="

            Heligmosomoides polygyrus
           
           (nematode)
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="1" text="
           C57BL/6 mice vaccinated 3 times with EVs + alum i.p.
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="1" text="
           Vaccination decreased worm burden by 82%.
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="1" text="
           Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="4" row="1" text="
           (
           
            Coakley et al., 2017
           
           )
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="2">
  <cell col="0" row="2" text="

            Trichuris muris
           
           (nematode)
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="2" text="
           C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="2" text="
           Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="2" text="
           Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="4" row="2" text="
           (
           
            Shears et al., 2018
           
           )
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="3">
  <cell col="0" row="3" text="

            Echinostoma caproni
           
           (trematode)
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="3" text="
           Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="3" text="
           No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="3" text="
           Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="4" row="3" text="
           (
           
            Trelis et al., 2016
           
           )
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
 </row>
 <row row="4">
  <cell col="0" row="4" text="

            Opisthorchis viverrini
           
           (trematode)
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="1" row="4" text="
           Hamsters vaccinated 3 times with EVs + alum i.p.
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="2" row="4" text="
           Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="3" row="4" text="
           Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
  <cell col="4" row="4" text="
           (
           
            Chaiyadet et al., 2019
           
           )
          ">
   <evidence statement_id="0" type="" version="">
   </evidence>
   <evidence statement_id="1" type="" version="">
   </evidence>
   <evidence statement_id="2" type="" version="">
   </evidence>
   <evidence statement_id="3" type="" version="">
   </evidence>
   <evidence statement_id="4" type="" version="">
   </evidence>
   <evidence statement_id="5" type="" version="">
   </evidence>
   <evidence statement_id="6" type="" version="">
   </evidence>
   <evidence statement_id="7" type="" version="">
   </evidence>
   <evidence statement_id="8" type="" version="">
   </evidence>
   <evidence statement_id="9" type="" version="">
   </evidence>
   <evidence statement_id="10" type="" version="">
   </evidence>
   <evidence statement_id="11" type="" version="">
   </evidence>
   <evidence statement_id="12" type="" version="">
   </evidence>
   <evidence statement_id="13" type="" version="">
   </evidence>
   <evidence statement_id="14" type="" version="">
   </evidence>
   <evidence statement_id="15" type="" version="">
   </evidence>
   <evidence statement_id="16" type="" version="">
   </evidence>
   <evidence statement_id="17" type="" version="">
   </evidence>
   <evidence statement_id="18" type="" version="">
   </evidence>
   <evidence statement_id="19" type="" version="">
   </evidence>
   <evidence statement_id="20" type="" version="">
   </evidence>
   <evidence statement_id="21" type="" version="">
   </evidence>
   <evidence statement_id="22" type="" version="">
   </evidence>
   <evidence statement_id="23" type="" version="">
   </evidence>
   <evidence statement_id="24" type="" version="">
   </evidence>
   <evidence statement_id="25" type="" version="">
   </evidence>
   <evidence statement_id="26" type="" version="">
   </evidence>
   <evidence statement_id="27" type="" version="">
   </evidence>
   <evidence statement_id="28" type="" version="">
   </evidence>
   <evidence statement_id="29" type="" version="">
   </evidence>
   <evidence statement_id="30" type="" version="">
   </evidence>
   <evidence statement_id="31" type="" version="">
   </evidence>
   <evidence statement_id="32" type="" version="">
   </evidence>
   <evidence statement_id="33" type="" version="">
   </evidence>
   <evidence statement_id="34" type="" version="">
   </evidence>
   <evidence statement_id="35" type="" version="">
   </evidence>
   <evidence statement_id="36" type="" version="">
   </evidence>
   <evidence statement_id="37" type="" version="">
   </evidence>
   <evidence statement_id="38" type="" version="">
   </evidence>
   <evidence statement_id="39" type="" version="">
   </evidence>
   <evidence statement_id="40" type="" version="">
   </evidence>
   <evidence statement_id="41" type="" version="">
   </evidence>
   <evidence statement_id="42" type="" version="">
   </evidence>
   <evidence statement_id="43" type="" version="">
   </evidence>
   <evidence statement_id="44" type="" version="">
   </evidence>
   <evidence statement_id="45" type="" version="">
   </evidence>
   <evidence statement_id="46" type="" version="">
   </evidence>
   <evidence statement_id="47" type="" version="">
   </evidence>
   <evidence statement_id="48" type="" version="">
   </evidence>
   <evidence statement_id="49" type="" version="">
   </evidence>
   <evidence statement_id="50" type="" version="">
   </evidence>
   <evidence statement_id="51" type="" version="">
   </evidence>
  </cell>
 </row>
 <statements>
  <statement id="0" text="The value of C57BL/6 mice vaccinated 3 times with EVs + alum i.p. for vaccination method used corresponds to the value of Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant for antibodies" type="">
  </statement>
  <statement id="1" text="The value of Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously for vaccination method used corresponds to the value of Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified for antibodies" type="">
  </statement>
  <statement id="2" text="The results is Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter when the antibodies is Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes" type="">
  </statement>
  <statement id="3" text="The vaccination method used is C57BL/6 mice vaccinated 3 times with EVs + alum i.p. when the results is Vaccination decreased worm burden by 82%." type="">
  </statement>
  <statement id="4" text="The results is Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter when the vaccination method used is Hamsters vaccinated 3 times with EVs + alum i.p." type="">
  </statement>
  <statement id="5" text="The antibodies is Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant when the results is Vaccination decreased worm burden by 82%." type="">
  </statement>
  <statement id="6" text="The value of Hamsters vaccinated 3 times with EVs + alum i.p. for vaccination method used corresponds to the value of Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes for antibodies" type="">
  </statement>
  <statement id="7" text="The vaccination method used is Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously when the results is No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice" type="">
  </statement>
  <statement id="8" text="The value of C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously for vaccination method used corresponds to the value of Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified for antibodies" type="">
  </statement>
  <statement id="9" text="The value of Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified for antibodies corresponds to the value of No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice for results" type="">
  </statement>
  <statement id="10" text="The value of C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously for vaccination method used corresponds to the value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results" type="">
  </statement>
  <statement id="11" text="The value of Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified for antibodies corresponds to the value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results" type="">
  </statement>
  <statement id="12" text="The value of Hamsters vaccinated 3 times with EVs + alum i.p. for vaccination method used corresponds to the value of No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice for results" type="">
  </statement>
  <statement id="13" text="The value of Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant for antibodies corresponds to the value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results" type="">
  </statement>
  <statement id="14" text="The vaccination method used is C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously when the antibodies is Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant" type="">
  </statement>
  <statement id="15" text="The results is Vaccination decreased worm burden by 82%. when the antibodies is Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified" type="">
  </statement>
  <statement id="16" text="The value of Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes for antibodies corresponds to the value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results" type="">
  </statement>
  <statement id="17" text="The value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results corresponds to the value of Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously for vaccination method used" type="">
  </statement>
  <statement id="18" text="The antibodies is Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes when the results is No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice" type="">
  </statement>
  <statement id="19" text="The value of Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant for antibodies corresponds to the value of Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously for vaccination method used" type="">
  </statement>
  <statement id="20" text="The results is Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter when the antibodies is Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified" type="">
  </statement>
  <statement id="21" text="The value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results corresponds to the value of Hamsters vaccinated 3 times with EVs + alum i.p. for vaccination method used" type="">
  </statement>
  <statement id="22" text="The value of C57BL/6 mice vaccinated 3 times with EVs + alum i.p. for vaccination method used corresponds to the value of Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control for results" type="">
  </statement>
  <statement id="23" text="The antibodies is Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified when the vaccination method used is C57BL/6 mice vaccinated 3 times with EVs + alum i.p." type="">
  </statement>
  <statement id="24" text="The value Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously belongs to vaccination method used" type="">
  </statement>
  <statement id="25" text="The value Hamsters vaccinated 3 times with EVs + alum i.p. belongs to vaccination method used" type="">
  </statement>
  <statement id="26" text="Vaccination deceased worm burden by ~60%. Lysed EVs had similar results to sham control is in results" type="">
  </statement>
  <statement id="27" text="Exosomes elicited IgM, IgG1, IgA and IgE isotypes reactive with EVs. Mice vaccinated with HES or HES supernatant also generated EV-responsive IgM. Sera from EV-vaccinated mice contained both IgM and IgG1 reactive reactive to HES and HES supernatant is in antibodies" type="">
  </statement>
  <statement id="28" text="The value Vaccination boosted IgG1 and IgG2a/c serum antibody responses to ES depleted of EVs. Range of IgG antibodies in sera against EV components 50–200 kDa in size. Possible targets identified belongs to antibodies" type="">
  </statement>
  <statement id="29" text="C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously is in vaccination method used" type="">
  </statement>
  <statement id="30" text="Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter is in results" type="">
  </statement>
  <statement id="31" text="The value Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified belongs to antibodies" type="">
  </statement>
  <statement id="32" text="Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes is in antibodies" type="">
  </statement>
  <statement id="33" text="Vaccination decreased worm burden by 82%. is in results" type="">
  </statement>
  <statement id="34" text="No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice is in results" type="">
  </statement>
  <statement id="35" text="C57BL/6 mice vaccinated 3 times with EVs + alum i.p. is in vaccination method used" type="">
  </statement>
  <statement id="36" text="The value Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes belongs to reference" type="">
  </statement>
  <statement id="37" text="The value No difference in worm burden seen. Vaccination decreased EPG by ~60%. Delay in parasite development. Increase in survival rate of mice belongs to antibodies" type="">
  </statement>
  <statement id="38" text="Vaccination decreased worm burden by 27%, EPG reduced by 32%. Average length of worms shorter is in vaccination method used" type="">
  </statement>
  <statement id="39" text="Hamsters vaccinated 3 times with EVs + alum i.p. is in antibodies" type="">
  </statement>
  <statement id="40" text="The value ( ) belongs to vaccination method used" type="">
  </statement>
  <statement id="41" text="Vaccination decreased worm burden by 82%. is in vaccination method used" type="">
  </statement>
  <statement id="42" text="The value C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously belongs to antibodies" type="">
  </statement>
  <statement id="43" text="Balb/c mice vaccinated twice with EVs no adjuvant subcutaneously is in reference" type="">
  </statement>
  <statement id="44" text="C57BL/6 mice vaccinated twice with EVs no adjuvant subcutaneously is in results" type="">
  </statement>
  <statement id="45" text="Exosomes elicited significant IgM and IgG response in serum. IgG1, 2b and 3 subtypes responsible for IgG increase. Antibodies against exosome/ESP components mainly 90 kDa in size. Bands the same for immunisation with exosomes and infected animals. Possible targets identified is in reference" type="">
  </statement>
  <statement id="46" text="The value Hamsters vaccinated 3 times with EVs + alum i.p. belongs to reference" type="">
  </statement>
  <statement id="47" text="Sera showed increase in IgG against EVs both pre and post challenge. Antibodies from vaccinated hamsters blocked uptake of EVs by cholangiocytes is in vaccination method used" type="">
  </statement>
  <statement id="48" text="Antibodies has all unique values." type="">
  </statement>
  <statement id="49" text="Vaccination method used has all unique values." type="">
  </statement>
  <statement id="50" text="Reference always has the same value." type="">
  </statement>
  <statement id="51" text="Results has all unique values." type="">
  </statement>
  <statement id="52" text="Reference has no duplicate values." type="">
  </statement>
  <statement id="53" text="Vaccination method used always has the same value." type="">
  </statement>
  <statement id="54" text="Results always has the same value." type="">
  </statement>
  <statement id="55" text="Antibodies always has the same value." type="">
  </statement>
 </statements>
</Table 2>
